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Among the various strategies to reduce the incidence of non-communicable diseases
reduction of sodium intake in the general population has been recognized as one of
the most cost-effective means because of its potential impact on the development of
hypertension and cardiovascular diseases. Yet, this strategic health recommendation
of the WHO and many other international organizations is far from being universally
accepted. Indeed, there are still several unresolved scientific and epidemiological
questions that maintain an ongoing debate. Thus what is the adequate low level of
sodium intake to recommend to the general population and whether national strategies
should be oriented to the overall population or only to higher risk fractions of the
population such as salt-sensitive patients are still discussed. In this paper, we shall
review the recent results of the literature regarding salt, blood pressure and cardiovascular
risk and we present the recommendations recently proposed by a group of experts of
Switzerland. The propositions of the participating medical societies are to encourage
national health authorities to continue their discussion with the food industry in order to
reduce the sodium intake of food products with a target of mean salt intake of 5–6 grams
per day in the population. Moreover, all initiatives to increase the information on the effect
of salt on health and on the salt content of food are supported.
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Introduction
The role of sodium in human physiology has been recognized more than two thousand years ago,
but the importance of maintaining an equilibrated sodium balance in order to maintain body
volumes and blood pressure (BP) has been demonstrated essentially by the pivotal publications of
Claude Bernard in the 1850’s on the regulation of the≪ milieu intérieur≫ and the fantastic work
of the physiologist Arthur Guyton and his studies on BP regulation and the kidney (Guyton et al.,
1980). Today it is well-accepted that an excessive salt intake is deleterious for health mainly because
a high salt intake favors the development of essential hypertension and its cardiovascular and renal
complications (Whelton et al., 2012; He et al., 2013; Kotchen et al., 2013; Mozaffarian et al., 2014).
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For these reasons the WHO recommendations as well as those of
many national medical societies encourage to lower salt intake in
the population (World Health Organisation, 2003).
Despite the accumulation of experimental, epidemiologic and
clinical data confirming a causal association between salt intake
and the risk of developing hypertension and cardiovascular
complications with recent data obtained in very large sets of
population (Mente et al., 2014; Mozaffarian et al., 2014) the
issue of salt intake in the population remains a matter of an
intensive scientific and political debate which is now going on
for several decades (He et al., 2013; Kotchen et al., 2013; Mente
et al., 2014). Indeed, the answers to several questions remain
highly controversial among the medical community. The first
regards the ideal amount of salt that should be consumed by the
population. The second concerns the pertinence of the proposed
strategies to reduce salt intake: should one continue to promote
a salt reduction in the entire population or would it be wiser
to target individuals at high risk of health complications due to
an excessive salt intake? At last could a diet too low in sodium
represent a risk and eventually increase the mortality risk as
suggested by some (Stolarz-Skrzypek et al., 2011; Graudal et al.,
2014; Mente et al., 2014), but contested by others (Cook et al.,
2014).
Recently a working group on Salt and Health has been created
in Switzerland under the patronage of the Swiss Foundation
of Cardiology and with the financial help of the Swiss Federal
Health authorities. The goal of this group of local experts
was to edit a position paper on salt and health in order
to clarify the position of the various medical specialties to
physicians and healthcare professionals and to support the
national strategy on salt in Switzerland that could help preventing
serious chronic diseases affecting adults as well as children. Thus,
specialists in hypertension, nephrology, cardiology, pediatric,
public health, geriatric, neurology, angiology, endocrinology,
nutrition, obstetric, internal medicine and general medicine have
been involved in the redaction of a position paper on salt.
This document has been published on the site of the Swiss
Foundation of Cardiology http://www.swissheart.ch/index.php?
id=2458&L=1) in German, French and Italian. The present article
is a reappraisal of this position paper in English in which themost
recent literature and considerations have been added.
Strategies to Reduce Salt Intake and
International Initiatives
For the World Health Organization (WHO) and the United
Nations reduction of salt intake in populations is considered
as a health strategy with the best cost/effectiveness to prevent
the development of non-communicable diseases such as
cardiovascular and renal diseases (Beaglehole et al., 2011). For
this reason, WHO has always supported national programs
aiming at reducing the mean salt intake of the general population
to a maximum of 5 g of sodium chloride (NaCl) or 2000mg
of sodium (Na). The World Hypertension League and the
International Society of Hypertension also support the position
of the WHO and together with the United Nations recommend
to participating countries to lower salt intake of their population
by 30% by 2025. In between several countries have established
their own national strategies and published guidelines with more
or less ambitious targets (He et al., 2010). Thus the United States
andGreat Britain recommend a salt intake of less than 6 g sodium
chloride per day and British even have a target of 3 g NaCl
until 2025 (He et al., 2010). In the countries of the European
community, the goal is to lower salt intake by 16% within 4 years
and Switzerland actively collaborates to the European Salt Action
Network. This Network has actually recognized the necessity to
evaluate the situation in each country, to define clear objectives,
to develop an information concept for the public, to accelerate
the collaboration with the industry and to establish a monitoring
system.
A recent review of the multiple national initiatives has
actually demonstrated that salt intake is relatively variable among
countries but generally varies between 6 and 12 g/day in adults
with a higher intake among men than women (Webster et al.,
2011). These data were confirmed recently in large survey
showing that salt intake exceeds the WHO recommendations
in 181 of 187 countries around the world (Powles et al., 2013;
Mozaffarian et al., 2014). (Figure 1) Depending on the local
traditions and eating habits salt intake may be as high as more
than 20 g NaCl per day. However, one should mention that the
various techniques used to assess salt intake may also contribute
to the observed variability as not all investigators used 24 h urine
collections, the reference technique, to measure salt intake.
Today, six countries have reported positive results of their
salt reducing strategy leading to a positive impact on the
population health i.e Finland, Great Britain, France, Ireland,
Japan, and recently Portugal (Polonia andMartins, 2009;Webster
et al., 2011). In Finland, the first country to have organized an
intervention to reduce salt intake at the national level, salt intake
has decreased by 3 g/day between 1978 and 2002. During the
same time period BP decreased significantly and cardiovascular
mortality and stroke declined by 60% (Laatikainen et al., 2006).
In Great Britain, between 2003 and 2011 salt intake decreased
by 1.4 g per day and was associated with a significant decrease
in BP and cardiovascular events but several other parameters
improved simultaneously such as smoking, cholesterol and
potassium intake (He et al., 2014). These examples demonstrate
the feasibility of these strategies but also emphasize the difficulty
to lower salt intake substantially over a short time period.
The Swiss Salt Strategy
In Switzerland, the Federal Office of Public Health has
elaborated a national strategy to reduce salt intake which is
called Salt Strategy 2008-2012. This program has now been
extended until 2016. The short-term goal of this program is
to reduce salt intake of the Swiss population initially to less
than 8 g/day and in the long-term to the recommended target
of <5 g/day. The first step of this national program was to
assess salt intake in the population in the context of the Swiss
Salt Study. The results of this study are available on the site:
http://www.bag.admin.ch/suchen/index.html?keywords=Salt&la
ng=fr&site_mode=intern&nsb_mode=yes&search_mode=AND
#volltextsuche (access verified in June 2015).
Frontiers in Physiology | www.frontiersin.org 2 August 2015 | Volume 6 | Article 227
Burnier et al. Salt consumption and cardiovascular complications
FIGURE 1 | Mean global sodium intakes in 2010, by country worldwide (from Powles et al., 2013).
In this national survey conducted in 2010 and 2011, 24 h
urines were collected in 1447 subjects aged >15 years and
randomly contacted throughout Switzerland taking into account
the three linguistic regions (French, German, and Italian). Results
show a mean salt intake of 7.8 g/day in women and 10.6 g/day
in men with little variations between the regions. As shown
in Figure 2, salt intake tends to be lower in the youngest
and oldest age categories both in men and women. In this
study only 21.6% of women and 6% of men had a salt intake
in line with the WHO recommendations. These figures are
quite similar to those reported in other surrounding European
countries (Webster et al., 2011). BP was also measured in all
participants and the prevalence of hypertension defined as a BP>
140/90mmHg or taking antihypertensive drugs was 25.6% with
a higher prevalence in men (32.3%) than in women (19.1%).
Interestingly, although sodium intake was comparable in the
3 linguistic regions, significant differences in the prevalence
of hypertension were observed between the 3 regions (higher
prevalence in the German speaking area and lower prevalence
in the Italian-speaking region). As reported in previous studies
a weak correlation was found between urinary sodium excretion
and BP but the correlation was stronger and significant in
subjects aged >50 years with an increase in systolic BP of
0.51mmHg for each gram of salt (p < 0.02).
The Swiss Salt Strategy shares many common points with
other national programs in Europe. Thus, authorities have
decided to establish a constructive dialog with the food industry
and the food producers (bakers, butchers, cheese makers. . . ) in
order to reduce salt in dietary products based on a voluntary basis
rather than on political constraints. There is also a strong will to
improve the population information not only by explaining the
potential risks of a salt excess but also by improving the labeling
of products in order to ameliorate the ability to choose food
FIGURE 2 | Salt intake based on 24h urinary sodium excretion in
Switzerland according to age and sex. Note that sodium intake is much
lower in women and that there is a trend for a lower salt intake in the youngest
and oldest age categories for both men and women.
products with a lower salt content. In parallel, several research
projects were supported to test the feasibility of lowering the salt
content of some basic products without affecting the taste and to
investigate whether reducing salt in collective restaurants would
be a pertinent approach.
Health Consequences of a High Salt Diet
The health consequences of an elevated salt intake have been
described in numerous experimental and observational studies
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(for review, see Alderman et al., 1998; Beaglehole et al., 2011;
Äijälä et al., 2015). Globally, studies have demonstrated that
a high salt diet increases BP and thereby increases the risk
of developing cardiac, cerebro-vascular, vascular and renal
complications. Several large population studies including our
Swiss Salt Study have demonstrated a positive association
between BP and the habitual sodium intake (Frost et al., 1991;
Elliott et al., 1996; Strazzullo et al., 2009; Joosten et al., 2014). The
INTERSALT study was one of the first to demonstrate a lower
prevalence of hypertension in populations with a low urinary
sodium excretion (Elliott et al., 1996). In this study the age-
associated increase in BP correlated closely with urinary sodium
excretion suggesting that the aging phenomenon is linked to
an increased salt sensitivity (Elliott et al., 1996). An association
between BP and a high sodium intake has also been observed
in children and adolescents (He and MacGregor, 2006). The
link between salt intake and BP has been recently re-emphasized
by the results of the Prospective Urban Rural Epidemiological
(PURE) study in which more than 100,000 subjects were enrolled
(Mente et al., 2014). In this study, two interesting observations
were made. The first is that the association of estimated intake
of sodium with BP was non-linear, a steeper association being
found with a higher sodium intake. The second is that the
association was most pronounced not only in persons consuming
high-sodium diets but also in persons with hypertension, and
older persons (Mente et al., 2014). Several other observational
studies had actually reported a causal relationship between
salt consumption and arterial hypertension and cardiovascular
diseases in various populations with sometimes contradictory
results (Alderman et al., 1998; He et al., 1999; Tuomilehto et al.,
2001; Zhao et al., 2004; Geleijnse et al., 2007).
As far as complications are concerned, a high salt diet has
been associated with an increased risk of stroke (Perry and
Beevers, 1992), left ventricular hypertrophy (Kupari et al., 1994;
Jin et al., 2009), proteinuria (Lambers Heerspink et al., 2012a),
and progression of chronic kidney diseases (CKD) (Lambers
Heerspink et al., 2012b) sometimes independently of the effect
of salt on BP. Salt excess also limits the antihypertensive effect
of drugs such as diuretics and blockers of the renin-angiotensin
system (Lambers Heerspink et al., 2012b). Finally, a high sodium
diet has been associated to an increased incidence of stomach
cancer (Joossens et al., 1996), metabolic syndrome (Chen et al.,
2009), obesity, an excessive consumption of soft drinks (He
et al., 2008) and to an increased risk of developing renal stones
(Cappuccio et al., 2000). Of note, many effervescent drugs have
been reported to contain a high amount of sodium (George et al.,
2013). A chronic consumption of these drugs may contribute to
increase the cardiovascular risk of patients (George et al., 2013).
The impact of salt on BP and cardiovascular events has also
been investigated in many interventional studies (1992; 1997;
Cappuccio et al., 1997; Whelton et al., 1998; Sacks et al., 2001;
Gates et al., 2004; He et al., 2009, 2013). The majority of these
studies have shown that reducing salt intake has a positive
effect on BP and on the incidence of cardiovascular and renal
complications and this is reflected in the results of several meta-
analyses and a Cochrane analysis (Midgley et al., 1996; Graudal
et al., 2012; He et al., 2013). In general the relation is weak
among individuals with a normal BP and probably a normal
capacity to excrete sodium and significantly more marked in
hypertensive and elderly patients characterized by a reduced
ability to excrete sodium. According to Strazzullo’s meta-analysis
a reduction of salt intake of 5–6 g/d is associated with a decrease
in systolic BP of 4–5mmHg and diastolic BP of 1–3mmHg
(Strazzullo et al., 2009). Similar figures were obtained in themeta-
analysis published by He et al. with a reduction of systolic BP of
5.4mmHg and diastolic BP of 2.8mmHg in hypertensive patients
reducing their salt intake by 100mmol/day, i.e., 5 g NaCl/day (He
et al., 2013). Although apparently small these decreases in BP
should be sufficient to induce a significant reduction of stroke
and cardiovascular events as a modest reduction of 3 g/day
has been estimated to substantially reduce cardiovascular events
(Bibbins-Domingo et al., 2010).
Salt Consumption in Children
Salt intake should not be severely restricted during pregnancy
because sodium is necessary for the volume expansion of
pregnant women. During the first years of the life and particularly
in very small children, a positive sodium balance is necessary
to promote an adequate body growth. Moreover, newborns and
premature babies are particularly exposed to renal sodium losses.
Therefore, they need a sufficient intake. Of note, breastfeeding
and specific newborn food preparations contain sufficient
amounts of salt to cover the needs. In adolescents, a high salt
intake has the same consequences as in adults i.e., an increase in
BP and weight gain (He and MacGregor, 2006) which may have
an impact on BP level in adulthood. In terms of healthcare policy
these issues are very relevant as an elevated BP in children and
adolescents is often associated with a high BP during adulthood.
In addition, the taste and eating habits are defined during
childhood. Thus children that have been used to eat high salt
meals will continue to prefer salty meals as adults. At last, in
children and adolescents salt is often associated with a high
consumption of soft drinks and sugar-containing drinks which
are major causes of overweight and obesity (He et al., 2008).
A Strategy for High Risk Groups or For the
Entire Population? The Concept of Salt
Sensitivity
The BP response to changes in sodium intake varies enormously
among individuals. Indeed, whereas some subjects can eat very
high amounts of salt without any modification of their BP,
others experienced a significant rise in BP with a sodium-rich
diet. This indicates that the BP response to changes in dietary
sodium is heterogeneous and this observation has led to the
development of the salt-sensitivity concept (Kawasaki et al.,
1978; Luft et al., 1991). The validity of this concept has been
challengedmany times but the clinical observation remains valid.
One concern has been the arbitrary definition of salt sensitivity
which had been defined by Weinberger et al. as an increase
in BP of more than 10% on high sodium diet (Weinberger,
1993). Thereafter many different definitions and approaches to
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characterize salt sensitivity have been proposed in order to be
more accurate. (Lungershausen and Howe, 1994). The arbitrary
dichotomization of the population has also been questioned.
Indeed, the distribution of salt-induced changes in BP is normal
and there is no evidence for a bimodal distribution. Therefore,
a salt-sensitive population could not be clearly defined. At last
there have been always some concerns about the reproducibility
of the determination of salt sensitivity (Zoccali et al., 1996;
Chiolero et al., 2001). Despite these criticisms, salt sensitivity
of BP remains a topic of clinical interest because of its public
health impact as a high salt sensitivity has been associated with
an increased risk of cardiovascular events and death (Morimoto
et al., 1997).
Salt-sensitivity is relatively common in the population. Thus
earlier studies have demonstrated that 30–50% of hypertensive
patients and 10–20% of normotensive subjects are salt-sensitive
(Weinberger et al., 1986). Certain groups of patients are more
sensitive to salt. This is the case for example of subjects or
patients of African origin and elderly patients. The prevalence
of salt-sensitivity may have increased in the last decades with
the rising prevalence of obesity, metabolic syndrome, type 2
diabetes, and CKD. Indeed, studies have demonstrated that
obesity and metabolic syndrome are associated with an increased
salt-sensitivity (Chen et al., 2009). This also clearly the case
for patients with CKD and a limited renal function (Kimura
et al., 2010). Interestingly if one considers the actual prevalence
of obesity, metabolic syndrome, diabetes, CKD, hypertension,
advanced age and subjects of African origin, the salt-sensitive
population may well represents more than 50% of the entire
population and this may actually justify a global salt strategy
rather than a strategy focused on high risk patients groups.
The salt sensitivity of BP is mediated by several mechanisms
involving the vessels, the brain, the kidneys and of course
genetics factors (Cowley, 1997; Weinberger, 2006a; Sanada et al.,
2011). Seminal experimental models such as those developed in
the rat by Dahl and collaborators (Dahl et al., 1962; Mattson
et al., 2008) and the recent description of several monogenic
forms of essential hypertension linking the development of
hypertension to a renal tubular defect limiting the excretion of
sodium have clearly demonstrated the crucial roles of genetic
factors and renal sodium handling in the salt-sensitive phenotype
(Lifton, 1996; Ji et al., 2008). Yet, many other factors have an
impact on the salt sensitivity of BP. Among them one has to
mention the hormonal profile (renin-angiotensin-aldosterone
system, sympathetic nervous system, sexual hormones. . . ) and
importantly renal function and the renal capacity to excrete
sodium (Chiolero et al., 2001; Weinberger, 2006b; Pechere-
Bertschi and Burnier, 2007).
The heterogeneity of the BP response to changes in salt
intake and the concept of salt-sensitivity has been the basis of
the question regarding the most adequate strategy to pursue in
order to reduce the negative clinical impact of a high sodium
consumption. Should one restrain sodium intake in the entire
population or only in salt-sensitive subjects and patients who are
at higher risk of developing hypertension and cardiovascular and
renal complications? For reasons of cost/effectiveness all national
and international prevention programs have decided to build
a strategy based on a global reduction of sodium consumption
in the entire population. This decision is based on several
observations. First, it is difficult to differentiate salt-sensitive
from salt-resistant individuals in clinical practice as there is no
easy tool to diagnose salt-sensitivity. Second, a modest reduction
in salt intake should be beneficial for all individuals including
young normotensive salt-resistant subjects whose phenotype
might actually change as they become older and loose part of
their capacity to excrete sodium with the renal aging process.
At last it seems important to sensitize the entire population
to the effects of salt and get them used to eat a salt-limited
diet if possible already during childhood and adolescence.
Some countries have actually combined the two strategies.
Thus national organizations have included both approaches in
their recommendations. For example, the American Institute
of Medicine proposes a target salt intake of <6 g NaCl /day
in the general population but a lower target (<3.8 g/day) in
some groups of subjects such as individuals older than 50 years,
hypertensive, diabetic or patients with renal diseases and subjects
of African-American origin (Institute of Medicine; Strategies
to reduce sodium intake in the United States, April 2010)
(www.iom.edu/Reports/2010/Strategies-to-Reduce-Sodium-Inta
ke-in-the-United-States.aspx). In Switzerland and most
European countries, no specific recommendation is proposed for
high risk groups despite their greater salt sensitivity.
Is There a Risk Associated With a Low Salt
Diet
In 2011, two observational studies were published simultaneously
which provided intriguing and challenging new findings in
clear opposition with most previously published studies. The
first study was conducted by Stolarz-Skrzypek and Staessen’s
group (Stolarz-Skrzypek et al., 2011). They assessed whether 24-
h urinary sodium excretion predicts BP and health outcomes
in a prospective population study, involving 3681 participants
without cardiovascular disease at baseline who were members of
families that were randomly enrolled in the Flemish Study on
Genes, Environment, and Health Outcomes (1985–2004) or in
the European Project on Genes in Hypertension (1999–2001).
Of 3681 participants without CVD, 2096 were normotensive at
baseline and 1499 had BP and sodium excretion measured at
baseline and last follow-up (2005–2008). Surprisingly, during the
7.9 years median follow-up, neither the risk of hypertension nor
the risk of cardiovascular disease was related to urinary sodium
excretion. In contrast, a low sodium excretion was associated
with a higher cardiovascular disease mortality (Stolarz-Skrzypek
et al., 2011). A rather similar observation was made by O’Donnell
et al. who looked at the association between estimated urinary
sodium and potassium excretion and cardiovascular events
in patients with established cardiovascular disease or diabetes
mellitus who participated in the Ongoing Telmisartan Alone
and in Combination with Ramipril Trial (ONTARGET) and the
Telmisartan Randomized Assessment Study in ACE-I Intolerant
Patients with Cardiovascular Disease (TRANSCEND) trials
(O’Donnell et al., 2011). In this very large study population of
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28,880 participants, compared with a baseline sodium excretion
of 4–5.99 g/day, sodium excretion of greater than 7 g/day was
associated with an increased risk of all cardiovascular events,
and a sodium excretion of less than 3 g daily was also associated
with increased risk of cardiovascular mortality suggesting a U-
shape curve of the relationship with an increased risk both at a
low and at a high sodium intake (Figure 3A) (O’Donnell et al.,
2011). Very recently, a similar observation was reported in a
meta-analysis including most recent studies (Graudal et al., 2014)
and in the PURE study and its 105,000 participants (Mente et al.,
2014).
These studies have been criticized for their methodology
regarding particularly the assessment of urinary sodium
excretion (Whelton et al., 2012). This was the case for the
PURE study and the first O’Donnell paper which did not use
24 h urine collections. There are also some doubts on whether
a single measurement can reliably predict mortality over a
prolonged follow-up period because of the variability of sodium
intake. Nonetheless, these observations tend to confirm that
an excessive salt intake (>15 g/day) is detrimental for health
but do not support the recommendations to lower salt intake
below 10 g/day. Interestingly, even in very high risk patients
such as patients with CKD, it remains difficult to demonstrate
FIGURE 3 | Relationship between urinary salt excretion and the hazard
ratio for cardiovascular events or death according to O’Donnell (A)
suggesting a U-shape curve and according to Cook RN suggesting a
linear relationship (B) (from O’Donnell et al., 2011; Cook et al., 2014).
that salt reduction reduces the risk of cardiovascular events and
the decline in renal function although clear benefits on BP and
proteinuria are consistently observed (McMahon et al., 2015).
In order to have a balanced view, one has to mention that
several other studies with perhaps a better methodology have
confirmed the clinical benefits of lowering salt intake (Äijälä
et al., 2015; Merino et al., 2015). In contrast to the U-shape
curve between urinary sodium excretion and cardiovascular
events published by O’Donnell, Cook et al. found a linear
relationship between the hazard ratio for cardiovascular events
and urinary sodium excretion at all levels of sodium excretion in
2275 participants not in a sodium reduction intervention having
participated in the THOP1 and THOP2 trials with 10–15 years
follow-up (Cook et al., 2014) (Figure 3B).
Thus, from the data available today, the American Institute of
Medicine has taken the following conclusions:
1. There is good evidence that a high salt consumption is
positively correlated with a higher risk of cardiovascular
events.
2. The evidence regarding the overall effects of salt on health are
not yet coherent with the efforts made to lower salt intake to
less than 3.75 g/d.
3. There is no strong evidence to restrict sodium intake more
drastically in some sub-groups of patients differently from the
entire population.
If a low salt diet is indeed associated with an increased incidence
of cardiovascular events and mortality, the important question
is what is the mechanism? Is this due to the low sodium
intake per se or to one or more concomitant factors that
might affect patients’ survival? One might also question whether
the low urinary sodium excretion observed in these patients
is a consequence rather than a cause of their higher risk of
cardiovascular complications. Indeed, in population studies,
the number of subjects consuming less than 2 g of sodium is
quite low. Thus intakes of this low level would seem likely
to be a marker of ill health and frailty leading to a higher
mortality. Today, the hypothesis of a deleterious effect of a low
sodium diet is not scientifically proven. Adequately designed
intervention studies should be done to answer this question.
Moreover, a careful examination of the clinical context of subjects
excreting a small amount of sodium every day should be done.
Indeed it is well possible that a low sodium excretion is just
a marker of risk and confounding factors may have played
an important role. For example excessive doses of diuretics
in heart failure, cirrhotic or diabetic, or CKD patients may
increase their risk of complications (Paterna et al., 2008; Ekinci
et al., 2011; Thomas et al., 2011). Yet, other hypotheses have
been proposed to explain the U-shape relationship. The first is
that a low sodium consumption is associated with a marked
compensatory stimulation of the renin-angiotensin-aldosterone
and of the sympathetic nervous system in order to maintain BP
(Graudal et al., 2012). Several experimental and clinical studies
have indeed shown that an activation of these hormonal systems
is associated to the development of target organ damages such as
left ventricular hypertrophy, vascular damages, proteinuria and
a decrease in renal function. In these situations, sodium has a
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catalytic effect to augment the deleterious effects of angiotensin II
and aldosterone and catecholamines (Brunner et al., 1972; Gavras
et al., 1976; Brilla andWeber, 1992; Pimenta et al., 2008; du Cailar
et al., 2010). However, one has to remember that these hormones
have much less deleterious effects when subjects or animals are
on a low sodium diet.
Another possible mechanism is the impact of a low sodium
diet on serum cholesterol. Indeed, higher levels of serum
cholesterol have been reported in subjects and patients with a
low urinary sodium excretion (Harsha et al., 2004; Graudal et al.,
2012) or on a low sodium diet as in the DASH trial (Sacks
et al., 2001). An effect on lipid metabolism could actually increase
cardiovascular events and mortality.
An excessive restriction of sodium in the diet may have
several other clinical inconvenients. In Alpine countries such
as Switzerland, iodine insufficiency is common and iodine
supplementation is done by adding iodine to the kitchen salt.
Recently, an adaptation of the iodine content of salt has occurred
in Switzerland based on the results of the Swiss Salt Study
(Haldimann et al., 2015). Reducing salt intake in the population
may further aggravate the iodine status of patients. In patients on
a low salt diet, there is also an increased risk of volume depletion
and hypotension in case of acute dehydration or diarrhea. In very
elderly, reducing sodium in the food may alter the food taste and
increase the risk of malnutrition (Zeanandin et al., 2012). Thus,
in elderly patients eating small amounts of food, sodium intake
should probably not be reduced.
Recommendations of the Swiss Specialists
Today, the recommendations of the Swiss Society of
Hypertension and the Swiss Society of Cardiology are in
agreement with those of European societies which recommend
a limitation of salt intake to less than 6 g/day for everybody.
Several Swiss medical societies (nephrology, neurology,
diabetology, pediatry, public health) do not have any specific
recommendations on salt but they tend to follow the WHO
guidelines or the recommendations of the cardiologists. The
Swiss strategy also emphasizes the need to focus particularly
on patients who have a high risk of developing arterial
hypertension or cardiovascular complications i.e., patients with
mild hypertension with or without target organ damage, subjects
with a family history of hypertension, elderly patients and
patients with chronic kidney and/or cardiac diseases, metabolic
syndrome, diabetes or obesity. This approach should have a
positive impact on the prevalence of hypertension in Switzerland
which reaches 26% of the general population in Switzerland and
more than 50% of Swiss older than 60 years. A modest reduction
of salt intake should also contribute to decrease cardiovascular
complications such as stroke, congestive heart failure and renal
insufficiency.
The Societies also acknowledge that salt reduction is one of
the approaches known to be effective in reducing cardiovascular
events and mortality in Switzerland and that other strategies
such as increasing potassium intake with fruits and vegetables,
regulating calories intake and limiting the consumption of
sweets and fat to prevent overweight and obesity should also be
implemented.
In this context, the position and the proposal of Swiss scientific
societies are the following:
1. At the national level, they invite the authorities to intensify
their efforts to implement the Salt Strategy 2013–2016 and
to mobilize necessary resources to this purpose. This strategy
aims at reducing salt consumption at the population level
below 8 g/day within 4 years and below 5 g/day in the long-
term.
2. Societies will collaborate with the authorities to obtain
sufficient financial support to favor research and to establish
an efficient monitoring of salt consumption in Switzerland.
3. Societies will increase their engagements in the information
of physicians and patients on the risks of a high salt diet, on
the means to promote a reduction of salt intake and on the
potential clinical benefits of lowering salt intake.
4. They will support all the efforts made to improve the
information of consumers with the development of better
labeling of food products as far as the salt content is
concerned.
5. Scientific societies will also support the authorities in their
efforts to convince the food industry to progressively lower
that salt content of their products in order to achieve the goals
of the Salt Strategy.
Members of the Working Group on Salt and
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